Track topics on Twitter Track topics that are important to you
Capillus to Showcase Its Laser Therapy Caps this week at Medica 2017
Miami, Florida (PRWEB) November 15, 2017
Capillus, LLC Capillus is making its inaugural appearance at the Medica 2017 World Forum for Medicine. Medica 2017 which is taking place this week in Dusseldorf, Germany runs from November 13th to November 16th, 2017.
Capillus is not only delighted to be a first-time exhibitor at Medica, but it is equally excited to showcase its complete line of laser therapy caps including the recently released CapillusRX™ which contains more lasers than any low-level laser therapy device in the market for home treatment of hair loss. Its 312 diodes provide maximum simultaneous coverage of the scalp by any device for treatment of hereditary hair loss. It is available only through the company’s global physician network.
Medica is the world's largest medical trade fair for medical technology, electro-medical equipment, laboratory equipment, diagnostics and pharmaceuticals. The fair is held annually and it is open to trade visitors only.
Capillus’ Chief Executive Officer, Carlos Piña, along with Chief Operating Officer, Maria Piña, Director of International Sales, Fernando Bermudez, and Director of International Distribution, Lisa Weaver will be attending Medica 2017.
“Capillus’ goal, during Medica 2017, is to showcase our full-line of laser therapy caps as an effective method of treating pattern baldness in men and women,” said Carlos Piña, Capillus Chief Executive Officer, “we wish to broaden our reach and educate distributors in all fields of medicine on how our products can help prevent hair loss and promote hair regrowth.”
Capillus will be meeting with major distributors from around the world including Mexico, South Korea, Saudi Arabia, and the United Arab Emirates during the Medica 2017 World Forum for Medicine.
In addition to its CapillusRX™ available only through its physician network, Capillus currently offers three FDA-Cleared laser caps for direct sale via http://www.capillus.com: 1) Capillus82™, an economical and convenient device with 82 laser diodes, 2) Capillus202™, a powerful yet affordable device containing 202 laser diodes, as well as 3) CapillusPRO™, a professional-grade device with 272 laser diodes. Capillus laser therapy caps use Low Level Laser Therapy technology (LLLT), which is a non-invasive and chemical-free medical treatment for hair loss. The Capillus laser therapy caps use a six-minute protocol which greatly reduces the time it takes to receive treatment. Capillus laser therapy caps are manufactured in the USA from foreign-source raw materials. The Capillus facility is ISO 13485 compliant, and it is located in Miami, Florida.
About Capillus, LLC
Capillus, LLC offers prescription and over-the-counter hair regrowth products and medical devices for both men and women suffering from hair loss. The Capillus premiere product lines include low-level laser therapy (LLLT) devices that are FDA-cleared and manufactured in the US under the highest-quality certification standard for the medical device industry (ISO13485). Capillus also offers additional non-prescription clinical hair products for hair and scalp health. Capillus products are available directly to the public for at-home use and also to their network of physicians for office use.
For more information visit https://www.capillus.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/11/prweb14921343.htmNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...